These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7640501)

  • 1. [Clinical study on fungus lipid-reducing capsule in regulating lipometabolic disorder].
    Lin QC; Ye Y; Fang SQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 May; 15(5):281-3. PubMed ID: 7640501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of youjiangzhi capsule on senile hyperlipidemia].
    Zhou WQ; Gao P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):428-9, 390. PubMed ID: 8251730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperlipidemic activity of adenosine triphosphate in rabbits fed a high-fat diet and hyperlipidemic patients.
    Zhang L; Liang L; Tong T; Qin Y; Xu Y; Tong X
    Pharm Biol; 2016 Oct; 54(10):2358-63. PubMed ID: 26955742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update of lipid lowering therapy].
    Riesen WF; Mordasini RC
    Praxis (Bern 1994); 2008 Nov; 97(22):1179-84. PubMed ID: 18979436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of hyperlipidemia].
    Kajiyama G; Horiuchi I
    Nihon Rinsho; 1990 Nov; 48(11):2620-8. PubMed ID: 2270030
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial.
    Hlais S; Reslan DR; Sarieddine HK; Nasreddine L; Taan G; Azar S; Obeid OA
    Clin Ther; 2012 Aug; 34(8):1674-82. PubMed ID: 22818869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical assessment on treatment of hyperlipidemia with pushen capsule].
    Liu ZL; Wu SX; Gao GD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Mar; 24(3):227-9. PubMed ID: 15074091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
    Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
    Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrefined and refined black raspberry seed oils significantly lower triglycerides and moderately affect cholesterol metabolism in male Syrian hamsters.
    Ash MM; Wolford KA; Carden TJ; Hwang KT; Carr TP
    J Med Food; 2011 Sep; 14(9):1032-8. PubMed ID: 21548801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the clinical benefits of lipid-disorder drugs.
    Hiatt WR; Smith RJ
    N Engl J Med; 2014 Jan; 370(5):396-9. PubMed ID: 24476429
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K;
    Atherosclerosis; 2008 Sep; 200(1):135-40. PubMed ID: 18667204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of the biological aging index and serum lipids in treatment with X50].
    Reuter W; Sauer I; Herrmann W
    Z Alternsforsch; 1986; 41(2):91-4. PubMed ID: 3754998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Jiangzhi koufu ye in the treatment of essential hyperlipemia].
    Liu J; Chang JJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Nov; 13(11):658-60, 643-4. PubMed ID: 8155940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipometabolic disorder--cholesterol and triglycerides].
    Luley C
    Clin Res Cardiol; 2006; 95 Suppl 6():VI17-22. PubMed ID: 17013580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical decrease in serum high-density lipoprotein cholesterol with Tredaptive® (m/r nicotinic acid 1 g and laropiprant 20 mg).
    Sharpe P
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):584-5. PubMed ID: 21868415
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
    Roth EM; McKenney JM; Kelly MT; Setze CM; Carlson DM; Gold A; Stolzenbach JC; Williams LA; Jones PH
    Am J Cardiovasc Drugs; 2010; 10(3):175-86. PubMed ID: 20524719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol.
    Toth PP; Zarotsky V; Sullivan JM; Laitinen D
    Curr Med Res Opin; 2009 Jun; 25(6):1355-63. PubMed ID: 19425901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.